152 related articles for article (PubMed ID: 9152370)
1. Cysteinyl leukotrienes induce P-selectin expression in human endothelial cells via a non-CysLT1 receptor-mediated mechanism.
Pedersen KE; Bochner BS; Undem BJ
J Pharmacol Exp Ther; 1997 May; 281(2):655-62. PubMed ID: 9152370
[TBL] [Abstract][Full Text] [Related]
2. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
Jonsson EW
Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
[TBL] [Abstract][Full Text] [Related]
3. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells.
Papayianni A; Serhan CN; Brady HR
J Immunol; 1996 Mar; 156(6):2264-72. PubMed ID: 8690917
[TBL] [Abstract][Full Text] [Related]
4. Studies of receptors and modulatory mechanisms in functional responses to cysteinyl-leukotrienes in smooth muscle.
Bäck M
Acta Physiol Scand Suppl; 2002 Feb; 648():1-55. PubMed ID: 11913222
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor agonists differentially regulate cysteinyl-leukotriene receptor 1 expression and function in human dendritic cells.
Thivierge M; Stankova J; Rola-Pleszczynski M
J Allergy Clin Immunol; 2006 May; 117(5):1155-62. PubMed ID: 16675346
[TBL] [Abstract][Full Text] [Related]
6. Cysteinyl leukotrienes and leukotriene B mediate vasoconstriction to arginine vasopressin in rat basilar artery.
Trandafir CC; Nishihashi T; Ji X; Wang A; Kurahashi K
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1027-33. PubMed ID: 16445567
[TBL] [Abstract][Full Text] [Related]
7. [Leukotrienes: potential therapeutic targets in cardiovascular diseases].
Bäck M
Bull Acad Natl Med; 2006 Oct; 190(7):1511-8; discussion 1518-21. PubMed ID: 17450683
[TBL] [Abstract][Full Text] [Related]
8. Peptido-leukotrienes are potent agonists of von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells.
Datta YH; Romano M; Jacobson BC; Golan DE; Serhan CN; Ewenstein BM
Circulation; 1995 Dec; 92(11):3304-11. PubMed ID: 7586318
[TBL] [Abstract][Full Text] [Related]
9. Functional studies of leukotriene receptors in vascular tissues.
Walch L; Norel X; Gascard JP; Brink C
Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 2):S107-11. PubMed ID: 10673237
[TBL] [Abstract][Full Text] [Related]
10. A second cysteinyl leukotriene receptor in human lung.
Labat C; Ortiz JL; Norel X; Gorenne I; Verley J; Abram TS; Cuthbert NJ; Tudhope SR; Norman P; Gardiner P
J Pharmacol Exp Ther; 1992 Nov; 263(2):800-5. PubMed ID: 1331415
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the human cysteinyl leukotriene CysLT1 receptor.
Lynch KR; O'Neill GP; Liu Q; Im DS; Sawyer N; Metters KM; Coulombe N; Abramovitz M; Figueroa DJ; Zeng Z; Connolly BM; Bai C; Austin CP; Chateauneuf A; Stocco R; Greig GM; Kargman S; Hooks SB; Hosfield E; Williams DL; Ford-Hutchinson AW; Caskey CT; Evans JF
Nature; 1999 Jun; 399(6738):789-93. PubMed ID: 10391245
[TBL] [Abstract][Full Text] [Related]
12. The CysLT1 ligand leukotriene D4 supports alpha4beta1- and alpha5beta1-mediated adhesion and proliferation of CD34+ hematopoietic progenitor cells.
Boehmler AM; Drost A; Jaggy L; Seitz G; Wiesner T; Denzlinger C; Kanz L; Möhle R
J Immunol; 2009 Jun; 182(11):6789-98. PubMed ID: 19454674
[TBL] [Abstract][Full Text] [Related]
13. Dominant expression of the CysLT2 receptor accounts for calcium signaling by cysteinyl leukotrienes in human umbilical vein endothelial cells.
Sjöström M; Johansson AS; Schröder O; Qiu H; Palmblad J; Haeggström JZ
Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):e37-41. PubMed ID: 12816881
[TBL] [Abstract][Full Text] [Related]
14. Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure.
Hui Y; Cheng Y; Smalera I; Jian W; Goldhahn L; Fitzgerald GA; Funk CD
Circulation; 2004 Nov; 110(21):3360-6. PubMed ID: 15545522
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of receptors for cysteinyl-leukotrienes in sheep trachealis muscle.
Jonsson EW
Pulm Pharmacol Ther; 1997; 10(1):29-36. PubMed ID: 9344830
[TBL] [Abstract][Full Text] [Related]
16. Leukotriene D4 and eosinophil transendothelial migration, superoxide generation, and degranulation via beta2 integrin.
Saito K; Nagata M; Kikuchi I; Sakamoto Y
Ann Allergy Asthma Immunol; 2004 Dec; 93(6):594-600. PubMed ID: 15609771
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of leukotriene receptor antagonists.
Aharony D
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):S214-9. PubMed ID: 9620942
[TBL] [Abstract][Full Text] [Related]
18. The ACh-induced contraction in rat aortas is mediated by the Cys Lt1 receptor via intracellular calcium mobilization in smooth muscle cells.
Mazzetti L; Franchi-Micheli S; Nistri S; Quattrone S; Simone R; Ciuffi M; Zilletti L; Failli P
Br J Pharmacol; 2003 Feb; 138(4):707-15. PubMed ID: 12598425
[TBL] [Abstract][Full Text] [Related]
19. The effects of leukotrienes C4 and D4 on ciliary activity of human paranasal sinus mucosa in vitro.
Ganbo T; Hisamatsu K; Inoue H; Mizukoshi A; Goto R; Murakami Y
Rhinology; 1995 Dec; 33(4):199-202. PubMed ID: 8919211
[TBL] [Abstract][Full Text] [Related]
20. Effects of leukotriene C4 and D4, histamine and bradykinin on cytosolic calcium concentrations and adhesiveness of endothelial cells and neutrophils.
Heimbürger M; Palmblad JE
Clin Exp Immunol; 1996 Mar; 103(3):454-60. PubMed ID: 8608646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
